Preview Newsletter

fosamax june 25

    Client Attorney Privileged/Attorney Work Product/At Request of Counsel

  1. Pharmalot.. Pharmalittle.. Good Morning: We’re Catching up on AstraZeneca, Marijuana and Lots More!!

    Jun 24, 2015 | The Wall Street Journal - Pharmalot

    By Ed Silverman

    ...A federal judge in Trenton, N.J., dismissed the last remaining 570 cases in multidistrict litigation over Merck’s osteoporosis drug Fosamax, but the cases could be reinstated if plaintiffs win an appeal pending before a federal appeals court, The New Jersey Law Journal writes...

    2. Full Text of Stories Below

    Client Attorney Privileged/Attorney Work Product/At Request of Counsel

  1. Pharmalot.. Pharmalittle.. Good Morning: We’re Catching up on AstraZeneca, Marijuana and Lots More!!

    Jun 24, 2015 | The Wall Street Journal - Pharmalot

    By Ed Silverman

    Good morning, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? While you ponder the possibilities, we will celebrate a gorgeous morning with some needed cups of stimulation. After the heat and humidity of the past few days, a sparkling sun and coooool breeze are quite welcome. And of course, we are happy to pass along the latest menu of tidbits to get you started on your way. Hope you have a smashing day and do stay in touch. We accept documents and tips…

    ...Pfizer has started a Phase III trial assessing an orphan drug called rivipansel as a treatment for sickle cell disease patients hospitalized with vaso-occlusive crisis, a common and very painful complication of the condition, Pharma Times says.

    A federal judge in Trenton, N.J., dismissed the last remaining 570 cases in multidistrict litigation over Merck’s osteoporosis drug Fosamax, but the cases could be reinstated if plaintiffs win an appeal pending before a federal appeals court, The New Jersey Law Journal writes.

    Hagens Berman Sobol Shapiro has conditionally agreed to pay Grunenthal $145,000 in sanctions for prosecuting three thalidomide injury suits a federal judge had determined were meritless, according to The Legal Intelligencer.

    For full story:

    http://blogs.wsj.com/pharmalot/2015/06/24/pharmalot-pharmalittle-good-morning-were-catching-up-on-astrazeneca-marijuana-and-lots-more/?KEYWORDS=fosamax


    Return to headline | Return to top

    2. Full Text of Stories Below

Add recipients

Suggested